Passage Bio(PASG)

1.31 -0.03 -2.2388%

今开:1.34昨收:1.34
最高:1.38 最低:1.3
涨停价:跌停价:
总市值:8.0711453E7

Passage Bio的热门讨论

持股变动声明

Passage Bio(PASG)03-20 04:15

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008495  Size: 5 KB 网页链接查看全文

其他

Passage Bio(PASG)04-09 18:05

$Passage Bio(PASG)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-044912  Act: 34  Size: 3 MB 网页链接查看全文

当期报告

Passage Bio(PASG)03-01 05:15

$Passage Bio(PASG)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-029361  Act: 34  Size: 201 KB 网页链接查看全文

持股变动声明

Passage Bio(PASG)02-14 08:45

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-003637  Size: 15 KB 网页链接查看全文

当期报告

Passage Bio(PASG)03-04 20:05

$Passage Bio(PASG)$ 8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0001558370-24-002309  Act: 34  Size: 6 MB 网页链接查看全文

持股变动声明

Passage Bio(PASG)03-20 04:15

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008489  Size: 5 KB 网页链接查看全文

持股变动声明

Passage Bio(PASG)03-20 04:15

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008491  Size: 5 KB 网页链接查看全文

超过5%股东持股披露「修订」

Passage Bio(PASG)04-13 05:45

$Passage Bio(PASG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-24-000373  Act: 34  Size: 114 KB 网页链接查看全文

生效批准

Passage Bio(PASG)04-17 18:05

$Passage Bio(PASG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000982  Act: 33  Size: 1 KB 网页链接查看全文

股东委托书协议

Passage Bio(PASG)04-09 18:05

$Passage Bio(PASG)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-044915  Act: 34  Size: 1 MB 网页链接查看全文

1 2

Passage Bio的最新讨论

Replix锐璞美股2021-04-05 19:19

$Passage Bio(PASG)$ Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
$Moderna(MRNA)$ $百济神州(BGNE)$查看全文

Replix锐璞美股2021-03-03 20:20

$Passage Bio(PASG)$ $PASG$ Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
- On track to initiate three Phase 1/2 clinical programs in the first half of 2021: PBGM01 for GM1 gangliosidosis (GM1), PBFT02 for frontotemporal dementi...查看全文

神圣的升值毁灭者2021-01-29 02:33

$Passage Bio(PASG)$ FDA批准了Passage Bio's(PASG-0.9%)PBFT02的网页链接查看全文

下一代罕见病基因疗法,砥砺前行

医药魔方2021-01-21 21:41

2020年1月,基因疗法开发商Generation Bio完成了1.1亿美元的C轮融资用以推进其A型血友病和苯丙酮尿症治疗药物的开发;5个月后,Generation又进行了首次公开募股(IPO),募资2.3亿美元。这无疑是一个迹象,表明投资者对下一代治疗罕见疾病的基因疗法非常感兴趣。
去年一年,尽管面临着各种挑战...查看全文

chuminhua2020-05-08 16:18

5/7,Passage Bio$Passage Bio(PASG)$ 与美国宾夕法尼亚大学去年达成合作,获得5款基因疗法,以及7个基因疗法的选择权。现在两家公司扩展了合作,增加了5个新项目,总计达到17个。合作期限也从2022年延长至2025年。作为回报,每年将向该大学提供500万美元。查看全文

chuminhua2020-02-28 23:21

2/27,Passage Bio$Passage Bio(PASG)$ 在Nasdaq IPO,发行价为18美元,共募集了2.16亿美元,比最初计划多72%。该公司聚焦基因疗法,与Frazier和OrbiMed合作,致力于开发罕见CNS单基因疾病的疗法。交易代码为$ PASG。查看全文

Passage Bio的公告

其他

$Passage Bio(PASG)$ POSASR Post-effective Amendment to an automatic shelf registration statement Accession Number: 0001558370-22-002714  Act: 33  Size: 792 KB 网页链接

持股变动声明

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787297-22-000004  Size: 10 KB 网页链接

持股变动声明

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787297-22-000006  Size: 5 KB 网页链接

持股变动声明

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787297-22-000005  Size: 9 KB 网页链接

持股变动声明

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787297-22-000003  Size: 5 KB 网页链接

持股变动声明

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787297-22-000002  Size: 5 KB 网页链接

持股变动声明

$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787297-22-000001  Size: 6 KB 网页链接

超过5%股东持股披露「修订」

$Passage Bio(PASG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-22-000424  Act: 34  Size: 103 KB 网页链接

超过5%股东持股披露「修订」

$Passage Bio(PASG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-039332  Act: 34  Size: 92 KB 网页链接

当期报告

$Passage Bio(PASG)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001558370-22-001039  Act: 34  Size: 4 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30